Y-mAbs Therapeutics Inc
NASDAQ:YMAB

Watchlist Manager
Y-mAbs Therapeutics Inc Logo
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Watchlist
Price: 4.71 USD 1.73% Market Closed
Market Cap: 213.3m USD

Relative Value

The Relative Value of one YMAB stock under the Base Case scenario is 9.01 USD. Compared to the current market price of 4.71 USD, Y-mAbs Therapeutics Inc is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

YMAB Relative Value
Base Case
9.01 USD
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
73
Median 3Y
4
Median 5Y
6.1
Industry
7.2
Forward
2.5
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-12.8
Industry
23.2
Forward
-4.4
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-13
Industry
19.3
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-12.9
Industry
22.5
vs History
79
vs Industry
35
Median 3Y
2.9
Median 5Y
5.2
Industry
2.7
vs History
71
vs Industry
68
Median 3Y
2.6
Median 5Y
5.2
Industry
7.5
Forward
1.8
vs History
63
vs Industry
68
Median 3Y
3
Median 5Y
3.7
Industry
9.4
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-8.7
Industry
4.6
Forward
-3
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-8.7
Industry
4.5
Forward
-3.2
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-10.5
Industry
4.9
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-10.5
Industry
3.7
vs History
84
vs Industry
36
Median 3Y
5.6
Median 5Y
10.7
Industry
4.9

Multiples Across Competitors

YMAB Competitors Multiples
Y-mAbs Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
213.1m USD 2.4 -7.5 -5 -5
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 202 723.3 -162 560.5 -197 400.3 -195 147.7
US
Abbvie Inc
NYSE:ABBV
337.5B USD 5.9 81.2 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.9B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10.5 -118.3 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 059.8 -525.6 -572.3 -557.1
AU
CSL Ltd
ASX:CSL
115.7B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.3B USD 4.1 12.7 11.3 12.7
US
Seagen Inc
F:SGT
39.3B EUR 19.8 -60.8 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.1B USD 17.1 -148.8 -666.4 -333.9
P/E Multiple
Earnings Growth PEG
US
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Average P/E: 34.2
Negative Multiple: -7.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 560.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.6 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Average EV/EBITDA: 15.5
Negative Multiple: -5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 400.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.3 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.3
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -666.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Average EV/EBIT: 20.1
Negative Multiple: -5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 147.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.1 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -333.9 N/A N/A